Global ELISA Kits Market

The global ELISA kits market was USD 2.35 Billion in 2022 and is likely to reach USD 4.28 Billion by 2031, expanding at a CAGR of 6.9% during 2023–2031. ELISA is a plate-based experiment designed to detect and quantify molecules, such as peptides, proteins, hormones, antibodies, and sometimes small molecules such as coenzymes and vitamins. Antibodies that are linked with enzymes are used to quantify the results. ELISA Kit (enzyme-linked immunosorbent assay) is mostly used technology in enzyme immunoassay technology. ELISA is also called an enzyme immunoassay (EIA), is a test that measures and detects antibodies or an antigen in the blood. ELISA is used as a diagnostic instrument in plant and medicine pathology. ELISA is used as a quality control check in different industries, such as biotech, food, and pharmaceutical industry. An ELISA test is used to diagnose:

• Lyme disease
• Syphilis
• Squamous cell carcinoma
• HIV, which causes AIDS
• Rotavirus

Get Free Sample Report

ELISA Kits Market Trends, Drivers, Restraints, and Opportunities

• The demand for ELISA kits is increasing in various industries such as pharmaceutical, biotechnology, food, plant pathology, and medicine, which in turn, is expected to propel the market during the forecast period.

• Increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer, is expected is drive the ELISA kit market over the timeline.

• Advancements in technology and increasing research & development are propelling the market.

• Growth in the biopharmaceutical and biotechnology industries is anticipated to drive the market.

• Rising healthcare infrastructure developments are expected to fuel the market.

• Availability of alternate immunoassays test is anticipated to hamper the growth of the global ELISA kits market during the forecast period.

• Increasing clinical trials and research & development activities are creating opportunities for the market players.

Scope of ELISA Kits Market Report

The report on the ELISA kits market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

ELISA Kits Market Segment Insights

The human ELISA Kit segment to hold significant market share

Based on product types, the ELISA Kits market is bifurcated into human ELISA Kit and animal ELISA Kit. The human ELISA Kit segment held a considerable share of the market in 2020 owing to integral study of human disease and advances in cures and treatments. The animal ELISA kit segment is anticipated to hold a considerable share of the market and continue to grow during the forecast period. Various companies such as IDEXX Laboratories provide animal health monitoring ELISA kits for the detection of diseases in camel, cat, birds, fish, duck, elephant, canine, hamster, goat, sheep, turkey, rabbit, whale, monkey, and ovine. An ELISA system has been developed for the diagnosis of canine parvovirus (CPV) or CPV antigen in dog feces.

Get Free Sample Report

The sandwich ELISA segment held substantial market share in 2020

Based on test types, the ELSIA kits market is divided into competitive ELISA, sandwich ELISA, multiple & portable ELISA, and indirect ELISA. The sandwich ELISA segment is expected to hold a significant share of the market and is anticipated to expand at high CAGR during the forecast period. Sandwich ELISA is suitable for complex samples, as antigen does not require purification prior to measurement.

The immunology segment held considerable market share

Based on applications, the global ELISA kits market is segmented into immunology, inflammation, infectious diseases, cancer, protein quantitation, and others. The immunology segment is estimated to hold a significant market share during the forecast period. The immune system, the body's defender, can work in cellular or humoral (innate or adaptive) forms. The foundation for the understanding immunological disease is the measurement and monitoring of changes in the immune response. ELISA has been shown in numerous studies to be the gold standard approach for such tests and monitoring that is both quick and cost-effective.

Get Free Sample Report

The academic institutes segment is anticipated to hold significant market share

Based on end-users, the global ELISA kits market is segmented into academic institutes, biopharmaceutical companies & pharmaceutical, contract research organizations (CROs), and research centers & laboratories. An academic institutes segment is projected to account for a significant share of the market, during the forecast period, owing to several institutes such as the Babcock University, Nigeria, BC Academic Health Council, Institute for Diagnostic Imaging Research (IDIR) at the University of Windsor, and the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) are conducting studies on molecules for detecting and diagnostics activities of infections and other applications. Growing R&D investment in the field of healthcare is expected to boost the demand for ELISA kits.

North America dominates the global market

In terms of regions, the global ELISA Kits market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market, due to increasing usage and favorable government regulations. The market in Europe is expected to grow at a rapid pace during the forecast period. Increasing awareness regarding the widespread usage in the pharmaceutical & healthcare industry and increasing government approvals for the use of ELISA kits propelling the market.

Get Free Sample Report

Segments

By Product Types

• Human ELISA Kit
• Animal ELISA Kit

By Test Types

• Sandwich ELISA
• Indirect ELISA
• Multiple and portable ELISA
• Competitive ELISA

By Applications

• Immunology
• Inflammation
• Infectious diseases
• Cancer
• Protein Quantitation
• Others

By End-users

• Academic Institutes
• Biopharmaceutical companies and pharmaceutical
• Contract Research Organizations (CROs)
• Research Centers and laboratories

By Regions

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

By Key Players

• Abcam plc.
• ABclonal, Inc.
• ADS Biotec Inc.
• American Laboratory Products Company (ALPCO)
• BD Biosciences
• BioLegend, Inc.
• Bio-Rad Laboratories, Inc.
• Boster Biological Technology
• Enzo Life Sciences, Inc.
• Mabtech
• Merck KGaA
• Mercodia AB
• R&D Systems, Inc.
• Thermo Fisher Scientific Inc.

Competitive Landscape

Key players in the global ELISA kits market include Abcam plc.; ABclonal, Inc.; ADS Biotec Inc.; American Laboratory Products Company (ALPCO); BD Biosciences; BioLegend, Inc.; Bio-Rad Laboratories, Inc.; Boster Biological Technology; Enzo Life Sciences, Inc.; Mabtech; Merck KGaA; Mercodia AB; R&D Systems, Inc.; and Thermo Fisher Scientific Inc. These players are focusing on strategies such as partnerships, collaborations, joint ventures, mergers and acquisitions, product launch, technological advancements, and R&D.